ABCA13 and oral cavity squamous cell carcinoma: Regarding oral squamous cell carcinoma, we observed 30 and 25 % of RTEL1 and ABCA13 amplification, respectively, but the presence of amplification was not statistically associated with clinicopathological data of patients.